Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.653
+0.009 (1.34%)
At close: Nov 20, 2024, 4:00 PM
0.670
+0.018 (2.70%)
After-hours: Nov 20, 2024, 7:18 PM EST
Predictive Oncology Employees
As of December 31, 2023, Predictive Oncology had 35 total employees, including 34 full-time and 1 part-time employees. The number of employees increased by 1 or 2.94% compared to the previous year.
Employees
35
Change (1Y)
1
Growth (1Y)
2.94%
Revenue / Employee
$42,406
Profits / Employee
-$399,147
Market Cap
4.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Check-Cap | 85 |
Biofrontera | 85 |
Hepion Pharmaceuticals | 22 |
Windtree Therapeutics | 20 |
Sonoma Pharmaceuticals | 10 |
Portage Biotech | 7 |
Creative Medical Technology Holdings | 4 |
Silo Pharma | 3 |
POAI News
- 8 days ago - Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - GlobeNewsWire
- 2 months ago - Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 - GlobeNewsWire
- 4 months ago - Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds - GlobeNewsWire
- 4 months ago - Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results - GlobeNewsWire
- 5 months ago - Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs) - GlobeNewsWire